Published in:
Volume 4 / Year 2015 / Issue 2

Norway, biosimilars in different funding systems. What works?

Page: 90-2

Abstract: Biosimilars can substitute treatment with expensive biological drugs and release money to treat more patients. Experience from Norway shows how this can be done with and without success. Submitted:… Read More »

Go Back Print